Previous stroke tied to higher risks in aortic valve replacement

(HealthDay)—For patients undergoing surgical aortic valve replacement (SAVR), previous stroke is a risk factor for recurrent ischemic stroke and major adverse cardiovascular events (MACE), according to a study published online April 25 in JAMA Cardiology. Charlotte Andreasen, M.D., from the Copenhagen University Hospital Herlev and Gentofte in Denmark, and colleagues conducted a cohort study involving 14,030 patients with aortic valve […]

Continue reading »

Contemporary update to PROGRESS-CTO International Registry shows successful outcomes

A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total Occlusion Intervention) International Registry was presented today as late-breaking clinical science at Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions 2018. The study includes results of Chronic Total Occlusion Percutaneous Intervention (CTO PCI) for more than 3,000 patients across 20 centers in the United […]

Continue reading »

Posting your vacation online may make you forget it

(HealthDay)—Over the past decade, smartphones and social media have blanketed the planet like a technological tsunami. The result is that nearly 70 million new photos and 5 billion new posts are uploaded to Instagram and Facebook every day, respectively. But a new study suggests that constantly sharing the moments of your life online may undermine your ability to remember the […]

Continue reading »

Controlling diabetes apart from blood sugar levels

When you have diabetes, there’s a lot of emphasis on controlling your blood sugar levels. And just as important, you and the health-care team caring for you should pay attention to cardiovascular, kidney and visual health. Dr. William Curry, vice chair for population health in Penn State Health’s Department of Family and Community Medicine, said he may do more good […]

Continue reading »

Experimental drug extends survival in progeria

A report from a clinical trial for a drug to treat the rapid-aging disorder progeria, published in this week’s Journal of the American Medical Association, offers hope for families with the ultra-rare genetic condition. Old Before Their Time Children with Hutchinson-Gilford Progeria Syndrome have a distinctive appearance, seemingly hurtling towards old age. After an outwardly normal infancy, weight gain slows, hair […]

Continue reading »

Brain cells record their activity in gene expression, new study finds

From burning your palm on a hot pan handle to memorizing the name of a new acquaintance, “anytime you experience something, your neurons are active,” says Kelsey Tyssowski, a graduate student in genetics at Harvard Medical School. Different experiences stimulate different patterns of activity in brain cells. Researchers want to track these activity patterns to better understand how the brain […]

Continue reading »

Researchers map the potential spread of yellow fever virus to cities around the world

The deadly yellow fever virus has the potential to spread into cities around the world where it previously hasn’t been seen, according to a new study led by St. Michael’s Hospital. Researchers led by Dr. Kamran Khan of St. Michael’s have mapped the worldwide pathways through which yellow fever virus could spread by analyzing global patterns of airline travellers, the […]

Continue reading »

Mouse study identifies new target for human accelerated aging syndrome

Scientists from the University of Cambridge have identified a potential therapeutic target in the devastating genetic disease Hutchinson-Gilford Progeria Syndrome (HGPS), which is characterised by premature ageing. In a paper published today in Nature Communications, scientists provide preclinical data showing that chemical inhibition or genetic deregulation of the enzyme N-acetyltransferase 10 (NAT10) leads to significant health and lifespan gains in […]

Continue reading »

Antibody ‘cocktail’ can prevent Zika infection but is not effective for treatment of fetuses

A “cocktail” of monoclonal antibodies that can prevent Zika virus (ZIKV) infection in primates was not effective for treatment of fetuses, according to a new collaborative study led by a University of Miami Miller School of Medicine research team. “We observed that ZIKV isolated from pregnant women in Rio de Janeiro also causes fetal infection in pregnant macaques. Unfortunately, we […]

Continue reading »
1 179 180 181 182 183 202